Drug-Device Combination Products Consultant in Delhi
The medical device industry in Delhi is a growing sector that produces a range of products including surgical instruments, diagnostic equipment, implants, and disposables. It is a hub for manufacturing and distribution of medical devices in North India.
Combination products are a unique category of medical products that combine two or more regulated components, including drugs, devices, and biological products. As a Drug Device Combination Products Consultant in Delhi, we provide comprehensive guidance on combination products under 21 CFR 3.2 (e).
Types of Drug-Device Combination Products
- Pre-filled syringes
- Drug-eluting stents
- Inhalers
- Transdermal patches
- Implantable drug delivery systems
- Drug-device combination products for diagnostics
- Drug-device combination products for drug delivery systems
- Drug-device combination products for gene therapy
Drug-Device Combination Products Consultant in Delhi?
Let’s have word about your next project
Benefits of Drug-Drug Combination Products
Despite the challenges, drug-device combination products offer many unique benefits over traditional drugs or devices alone, such as targeted therapy, improved drug delivery, and increased patient compliance. They represent an exciting and growing area of innovation in the healthcare industry, with the potential to improve patient outcomes and quality of life.
If you are looking for expert guidance in the development and regulation of drug-device combination products in Delhi, Operon Strategist can help. Our team of experienced consultants offers a range of services. Contact us today to learn more.
FAQs
What is a drug-device combination product?
A drug-device combination product is a medical product that combines two or more regulated components such as a drug, device, or biological product into a single entity. As defined under 21 CFR 3.2(e) by the U.S. Food and Drug Administration, these products are regulated based on their Primary Mode of Action (PMOA).
How are drug-device combination products regulated in India?
In India, regulation depends on the primary mode of action and is overseen by the Central Drugs Standard Control Organization. Manufacturers must comply with the Medical Device Rules, Drugs & Cosmetics Act, and applicable CDSCO guidance.
What is Primary Mode of Action (PMOA)?
Primary Mode of Action (PMOA) determines whether the product will be regulated primarily as a drug or a device. This classification impacts:
Documentation requirements
Clinical study obligations
Regulatory pathway
Review authority
Why is regulatory consulting important for combination products?
Combination products involve dual compliance (drug + device). Regulatory consulting helps with:
Classification strategy
Technical documentation
Risk management and QMS alignment
Clinical evaluation strategy
Global market entry planning
What are the benefits of drug-device combination products?
These products offer:
Targeted therapy
Controlled drug release
Improved patient compliance
Enhanced therapeutic outcomes
Reduced dosing errors
They represent one of the fastest-growing innovation segments in the healthcare industry.